![Glenda S. Overbeck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Glenda S. Overbeck
Direktor/Vorstandsmitglied bei
Oncovance Technologies, Inc.
Profil
Glenda S.
Overbeck is currently a Director at Oncovance Technologies, Inc. and Prokaryon Technologies, Inc. She previously worked as a Vice President at BCM Technologies, Inc. from 2000 to 2009.
She also held positions as an Associate at Houston Partners and as a Principal at Progression Therapeutics, Inc. Ms. Overbeck obtained her undergraduate degree and an MBA from Pittsburg State University.
Aktive Positionen von Glenda S. Overbeck
| Unternehmen | Position | Beginn |
|---|---|---|
Oncovance Technologies, Inc.
 Oncovance Technologies, Inc. Information Technology ServicesTechnology Services Provides information management and analytical services | Direktor/Vorstandsmitglied | 18.08.2009 |
Prokaryon Technologies, Inc.
 Prokaryon Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets products to prevent and control infectious diseases in animals | Direktor/Vorstandsmitglied | 17.08.2009 |
Ehemalige bekannte Positionen von Glenda S. Overbeck
| Unternehmen | Position | Ende |
|---|---|---|
BCM Technologies, Inc.
 BCM Technologies, Inc. Investment ManagersFinance BCM Technologies invests in companies located in the United States. The firm focuses on sectors such as medicine, pharmaceutical and life science. It participates in seed and early stage capital transactions. It acts as a lead investor and also makes co-investments. | Private Equity Investor | 30.06.2009 |
Houston Partners
 Houston Partners Investment ManagersFinance Acts as an alternative investment manager | Corporate Officer/Principal | 31.12.1999 |
Progression Therapeutics, Inc.
 Progression Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops prognostic tests and therapies for the treatment cancer | Direktor/Vorstandsmitglied | 19.08.2009 |
Ausbildung von Glenda S. Overbeck
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
19
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
BCM Technologies, Inc.
BCM Technologies, Inc. Investment ManagersFinance BCM Technologies invests in companies located in the United States. The firm focuses on sectors such as medicine, pharmaceutical and life science. It participates in seed and early stage capital transactions. It acts as a lead investor and also makes co-investments. | Finance |
Pittsburg State University
 Pittsburg State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Houston Partners
Houston Partners Investment ManagersFinance Acts as an alternative investment manager | Finance |
Oncovance Technologies, Inc.
Oncovance Technologies, Inc. Information Technology ServicesTechnology Services Provides information management and analytical services | Technology Services |
Progression Therapeutics, Inc.
Progression Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops prognostic tests and therapies for the treatment cancer | Health Technology |
Prokaryon Technologies, Inc.
Prokaryon Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets products to prevent and control infectious diseases in animals | Health Technology |
